Investor directory
Fund+
Fund+ is dedicated to fostering innovation in the life sciences sector in Belgium.
The facts
- Typical cheque
- €5M – €15M
- Headquarters
- Leuven, Belgium
- Founded
- 2015
Selected portfolio
iTeos TherapeuticsOna TherapeuticsExeVirAelin TherapeuticsMinoryxCellaïonNOVADIPeTheRNAOctimet OncologyConfo TherapeuticsEyeD PharmaIndigo (Monitoring Equipment)Coave TherapeuticsImmunic Therapeutics (NAS: IMUX)AstriVaxEpics TherapeuticsEgle TherapeuticsCardiorTubulisTargED Biopharmaceuticals
Are you Fund+? Tell us what to correct and we will update it — or ask us to remove the entry.